J
Jee Hyun Kim
Researcher at Seoul National University Bundang Hospital
Publications - 703
Citations - 12600
Jee Hyun Kim is an academic researcher from Seoul National University Bundang Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 46, co-authored 319 publications receiving 9907 citations. Previous affiliations of Jee Hyun Kim include Seoul National University & New Generation University College.
Papers
More filters
Journal ArticleDOI
Five-Year Follow-up Study of Monoclonal Gammopathy of Undetermined Significance in a Korean Elderly Urban Cohort.
Yun Gyoo Lee,Soo Mee Bang,Jeong Ok Lee,Jin Won Kim,Keun-Wook Lee,Jee Hyun Kim,Junghan Song,Tae Hee Kim,Ki Woong Kim,Jong Seok Lee +9 more
TL;DR: 5-year follow-up data show that the natural clinical course of MGUS in Korea is similar to that in Western countries, and MGUS was not associated with an increased risk of death over the 5-year study period.
Journal ArticleDOI
Impact of Intratumoral Expression Levels of Fluoropyrimidine-Metabolizing Enzymes on Treatment Outcomes of Adjuvant S-1 Therapy in Gastric Cancer
Jiyeon Kim,Eun Shin,Jin Won Kim,Hye Seung Lee,Dae Won Lee,Se Hyun Kim,Jeong Ok Lee,Yu Jung Kim,Jee Hyun Kim,Soo Mee Bang,Sang Hoon Ahn,Do Joong Park,Jong Seok Lee,Ju Seog Lee,Hyung Ho Kim,Keun Wook Lee +15 more
TL;DR: GC patients with high intratumoral D PD expression did not have inferior outcome following adjuvant S-1 therapy compared with those with low DPD expression, but low intratumoran DPDexpression was related to poor DFS.
Journal ArticleDOI
Cisplatin-Based Combination Chemotherapy for Advanced Hepatocellular Carcinoma: A Single Center Experience before the Sorafenib Era
Nae Yu Kim,Jong Mu Sun,Kim Yk,Keun-Wook Lee,Jee Hyun Kim,Soo Mee Bang,Jin Wook Kim,Sook-Hyang Jeong,Jong Seok Lee +8 more
TL;DR: Cisplatin-based combination chemotherapy in patients with advanced HCC has a low response rate and short TTP regardless of the chemotherapy regimen used, and patients with a good ECOG PS and without PVT can be considered candidates for cisplatin in combination chemotherapy.
Journal ArticleDOI
Treatment outcome of adult acute lymphocytic leukemia with VPD(L) regimen: analysis of prognostic factors.
Sook Ryun Park,Jee Hyun Kim,Do Yeun Kim,Se-Hoon Lee,Sang Yoon Lee,In Sil Choi,Sung-Soo Yoon,Seon Yang Park,Byuoung Gook Kim,Noe Kyoung Kim +9 more
TL;DR: Despite an initial excellent response to the VPD (L) regimen, newer therapeutic strategies, including more intensive postremission therapies, are urgently needed because of the high relapse rate.
Journal ArticleDOI
Survival Benefit of Surgical Removal of Primary Tumor in Patients With Stage IV Breast Cancer.
Hye Jin Kim,Eunyoung Kang,Jee Hyun Kim,Se Hyun Kim,Yu Jung Kim,In Ah Kim,Keun Yong Eom,Su Min Chae,Kyu Min Kang,Eun Kyu Kim,Sung-Won Kim +10 more
TL;DR: The results showed that primary tumor removal was independently associated with improvement in survival, and surgical management for the primary tumor could be considered more actively in patients with stage IV breast cancer.